Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
4.740
+0.220 (4.87%)
At close: May 12, 2025, 4:00 PM
4.650
-0.090 (-1.90%)
After-hours: May 12, 2025, 6:54 PM EDT

Jasper Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-78.78-71.27-64.47-37.69-30.64-31.67
Upgrade
Depreciation & Amortization
1.361.371.110.980.38-
Upgrade
Loss (Gain) From Sale of Assets
0.010.01----
Upgrade
Stock-Based Compensation
7.266.625.214.091.051.21
Upgrade
Other Operating Activities
0.570.490.98-12.59-6.0910.9
Upgrade
Change in Accounts Receivable
--0.66-0.660.6-
Upgrade
Change in Accounts Payable
0.6-0.122.38-2.152.940.36
Upgrade
Change in Other Net Operating Assets
-0.730.32.062.17-1.920.94
Upgrade
Operating Cash Flow
-69.71-62.6-52.07-45.86-33.68-18.27
Upgrade
Capital Expenditures
-0.53-0.55-0.27-0.58-2.43-
Upgrade
Sale of Property, Plant & Equipment
0.020.02----
Upgrade
Investing Cash Flow
-0.5-0.53-0.27-0.58-2.43-
Upgrade
Issuance of Common Stock
0.5447.88101.930.060.240.05
Upgrade
Repurchase of Common Stock
---0.96---
Upgrade
Other Financing Activities
----89.98-
Upgrade
Financing Cash Flow
0.5447.88100.970.06100.9711.29
Upgrade
Net Cash Flow
-69.68-15.2548.64-46.3864.86-6.98
Upgrade
Free Cash Flow
-70.24-63.15-52.33-46.43-36.11-18.27
Upgrade
Free Cash Flow Per Share
-4.68-4.33-5.01-12.73-31.69-105.60
Upgrade
Levered Free Cash Flow
-44.36-39.59-30.35-29.17-22.8-10.54
Upgrade
Unlevered Free Cash Flow
-44.36-39.59-30.35-29.17-22.8-10.54
Upgrade
Change in Net Working Capital
-0.04-0.62-6.631.67-1.22-1.17
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q